Delivery Order SPE2DB20D2014-SPE2DB24FA95G
Award Date 1/30/24
Potential Completion Date 1/31/24
Potential Value $29K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $10,637.56 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,298,990 units of Insulin Aspart 100 Unit/mL pen 3mL. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The IDC allows the DLA to efficiently procure a...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $1,106.01 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Insulin Aspart 100 Unit/ML Pen 3ML. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4563449313 - Insulin Aspart 100 Unit/mL Pen 3mL. The contract has a potential value of $3,329.97 and a completion date of January 26, 2024. Amerisourcebergen Drug Corp, as the prime contractor, will deliver the pharmaceutical product from its facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, to provide 4,563,557,490 units of insulin aspart 100 unit/mL pens. The $7,975.68 contract has a completion date of February 6, 2024 and was awarded on February 5, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,335,048 units of Insulin Aspart 100 Unit/mL Pen 3mL. The $20,817.40 delivery order has a completion date of January 17, 2024. Amerisourcebergen Drug Corp, a for-profit organization, has previously received numerous federal contract awards from DLA Troop Support Medical to provide pharmaceuticals, medical supplies, and...
- The U.S. Department of Defense's Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,563,299,186 units of Insulin Aspart 100 Unit/mL Pen 3mL. The $3,659.20 delivery order has a completion date of January 11, 2024. AmerisourceBergen Drug Corp is a prime contractor that has received numerous federal contract awards from the DLA to supply pharmaceuticals, medical...
- The U.S. Defense Logistics Agency (DLA) awarded a $30,545.47 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to provide 4562981740 units of Insulin Aspart 100 Unit/mL Pen 3mL. This contract has an ultimate completion date of December 5, 2023 and was awarded on December 4, 2022. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a for-profit organization and major pharmaceutical distributor that maintains an...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Insulin Aspart 100 Unit/mL Pen 3mL. The order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by the parent company, Cencora, Inc., doing business as AmerisourceBergen. This IDC serves as the primary vehicle for AmerisourceBergen to deliver a comprehensive range of pharmaceutical products and...
- The U.S. Defense Logistics Agency (DLA) awarded a $3,659.20 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The order is for the delivery of insulin aspart 100 unit/ml pen 3ml to support DLA Troop Support Medical operations. This delivery order is part of Amerisourcebergen Drug Corp's existing indefinite delivery contract with DLA to provide pharmaceuticals and medical supplies. No...
- The Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at $2,195.52, is for the provision of Insulin Aspart 100 unit/mL pens with a completion date of January 31, 2024. Amerisourcebergen Drug Corp serves as the prime contractor on this delivery order, which is part of a larger indefinite delivery...